Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.16 USD | +0.44% | +0.41% | +25.26% |
Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.26% | 10.12B | |
+25.52% | 661B | |
+26.74% | 566B | |
-6.53% | 352B | |
+20.34% | 332B | |
+2.96% | 283B | |
+13.43% | 231B | |
+4.70% | 200B | |
-9.41% | 195B | |
-5.24% | 145B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- JPMorgan Chase Adjusts Price Target on Catalent to $48 From $45, Maintains Neutral Rating